Skip to content

Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial

Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07316946
Enrollment
62
Registered
2026-01-05
Start date
2026-02-13
Completion date
2026-07-30
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Keywords

neuromuscular taping, pain, function, shoulder

Brief summary

Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial

Detailed description

Randomized clinical trial 2 arms

Interventions

OTHERExperimental Group

The experimental group will receive a multilayer neuromuscular taping application using kinesiotape, consisting of the placement of two longitudinal strips in the direction of the lower trapezius, applied with tension close to 100% of the tape's elastic capacity. During the application, participants will be asked to activate the scapular depressor and retractor muscles. Additionally, two other longitudinal strips will be applied from the anterior portion of the humeral head toward the scapular spine, also with tension close to 100%. During this application, participants will be asked to activate the rotator cuff through a posteroanterior push of the humeral head.

OTHERPlacebo Group

The placebo group will receive the same taping, with an identical arrangement of the strips, but without applying any tension (0%) to them. In addition, participants will not receive any instructions regarding muscle activation during the application. This placebo taping model has been used in previous studies, supporting its methodological validity.

Sponsors

Sandra Jiménez-del-Barrio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

participants and outcome assessors will be blinded

Intervention model description

Randomized clinical trial 2 arms

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age over 18 years * compete in a sport that involves overhead movement patterns * train at least 2 hours per week * shoulder pain lasting more than six weeks * shoulder pain related to sports activity * understand Spanish fluently enough to complete the questionnaire assessment.

Exclusion criteria

* presence of red flags that could suggest fractures, dislocations, or complete tendon ruptures, among others * neurological pathologies * other severe pathologies such as inflammatory arthritis, frozen shoulder * having received corticosteroid injections or physiotherapy treatment in the last six months * presence of previous surgeries * pregnancy * cognitive deficits that could limit the comprehension of the questionnaires or the physical evaluation * skin problems that would be a contraindication for any type of bandage.

Design outcomes

Primary

MeasureTime frameDescription
Actual Pain IntensityBaseline, after 30 minutes of the intervention and 72 hours after intervencionPain intensity will be assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to rate the intensity of pain experienced at the time of measurement
Pain Intensity during the arm elevationBaseline, 30 minutes after intervention and 72 hours after interventionPain intensity will be assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to rate the intensity of pain experienced during arm elevation.

Secondary

MeasureTime frameDescription
Static Scapular PositionBaseline, 30 minutes after intervention and 72 hours after interventionScapular position will be measured using an anterior/posterior scale. This static position will be recorded while standing, using a digital clinometer installed on a smartphone (Clinometer app). The inclinometer will be positioned directly over the scapular spine in the direction of the infraglenoid fossa.
Range of MotionBaseline, 30 minutes after intervention and 72 hours after interventionPain-free ROM during shoulder flexion, adduction, internal rotation, and external rotation will be measured following the protocol described by Shin et al.Participants will be instructed to flex the affected arm as far as possible, keeping the thumb pointing toward the ceiling. For adduction measurement, the patient will be placed in the side-lying position, and the evaluator will manually stabilize the scapula against the patient's thorax, allowing the arm to hang horizontally in adduction. For internal and external rotation, participants will be positioned supine with the shoulder abducted to 90°, the elbow flexed to 90°, and the forearm in a neutral position. A rolled towel will be placed under the humerus to maintain shoulder alignment. Participants will be asked to rotate their arm until pain onset or until scapular movement is observed. Three attempts of each movement will be recorded, and the mean range of motion (ROM) will be used for statistical analysis.
Functional CapacityBaseline, 30 minutes after intervention and 72 hours after interventionFunctional capacity will be assessed using the SPADI questionnaire. The SPADI is a patient-reported outcome measure designed to assess shoulder pain and functional disability. It consists of 13 items divided into two domains: pain and disability. The total score will be calculated by summing both domains and converting the result to a scale of 0 to 100, where higher scores indicate greater pain and disability.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026